Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

The global control and prevention of cervical cancer caused by HPV

Prof Thomas Broker - University of Alabama, Birmingham, USA
The global control and prevention of cervical cancer caused by HPV ( Prof Thomas Broker - University of Alabama, Birmingham, USA )
11 Apr 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML)

Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013

Treating ALL patients with T cells targeted for CD19

Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA
Treating ALL patients with T cells targeted for CD19 ( Dr Laurence Cooper - MD Anderson Cancer Center, Houston, USA )
8 Dec 2013

Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL

Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
Chimeric antigen receptor produces complete responses and long-term persistence in children and adults relapsed, refractory ALL ( Dr. Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies

Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
Long-term functional persistence, B cell aplasia and anti-leukaemia efficacy in refractory B cell malignancies ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence

Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA
T cells engineered with chimeric antigen receptor targeting CD19 produce significant long-term persistence ( Dr Stephen A. Grupp - University of Pennsylvania, Philadelphia, USA )
8 Dec 2013

Removal of alpha/beta T cells and of CD19 B cells in children With acute leukaemia

Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy
Removal of alpha/beta  T cells and of CD19  B cells in children With acute leukaemia ( Dr Alice Bertaina - IRCCS Bambino Gesù Children's Hospital, Rome, Italy )
8 Dec 2013

Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531

Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA
Results from the randomised phase III Children’s Oncology Group (COG) trial, AAML0531 ( Dr Alan Gamis - Children’s Mercy Hospital, Kansas City, USA )
8 Dec 2013

IMCPO, legal aspects of being an oncologist and the latest treatment for lung cancer in India

Dr Purvish Parikh - President of the Indian Society for Medical and Paediatric Oncology (ISMPO)
IMCPO, legal aspects of being an oncologist and the latest treatment for lung cancer in India ( Dr Purvish Parikh - President of the Indian Society for Medical and Paediatric Oncology (ISMPO) )
4 Dec 2013

Childhood cancer registries in Africa

Dr Daniela Cristina Stefan - Stellenbosch University & Tygerberg Hospital, South Africa
Childhood cancer registries in Africa ( Dr Daniela Cristina Stefan - Stellenbosch University & Tygerberg Hospital, South Africa )
2 Dec 2013

Pathology and diagnosis of nephroblastoma

Dr Gordan Vujanic – University of Cardiff, UK
Pathology and diagnosis of nephroblastoma ( Dr Gordan Vujanic – University of Cardiff, UK )
27 Nov 2013